Jinkyu Jung

Title: Jinkyu Jung: Innovator in Tumor Metastasis Research

Introduction

Jinkyu Jung is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of cancer research, particularly in the area of tumor metastasis. His innovative work has led to the development of methods that could potentially change the landscape of cancer treatment.

Latest Patents

Jinkyu Jung holds a patent for the "Use of cysteamine and derivatives thereof to suppress tumor metastases." This patent outlines methods for inhibiting or suppressing the metastasis of tumors in mammalian subjects using cysteamine products, such as cysteamine or cystamine. Additionally, it describes a method for treating pancreatic cancer by administering these cysteamine products.

Career Highlights

Throughout his career, Jinkyu Jung has worked with various organizations, including Meshaberase, LLC and the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in these institutions has allowed him to further his research and contribute to advancements in medical science.

Collaborations

Jinkyu Jung has collaborated with notable individuals in his field, including Benjamin Morris Rubin and Mark Gilbert. These collaborations have enriched his research and expanded the impact of his work in cancer treatment.

Conclusion

Jinkyu Jung's innovative research and patent contributions are paving the way for new approaches to cancer treatment, particularly in suppressing tumor metastasis. His work exemplifies the importance of innovation in the medical field and its potential to save lives.